FOXM1 and glioblastoma: These findings collectively show that circ-PIK3C2A acts as a ceRNA via modulating the miR-877-5p/FOXM1 axis, opening up a unique avenue for future clinical intervention with glioblastoma [108] (Figure 4 and Table 2).